GlassScriptPhysician profile
Marisa K Austin
NPI 1528207594
$9,998.63
in general payments reported to CMS, 2019-2025
31 companies · $1,737 in 2025
The $1,737 reported for 2025 was more than what 94% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,001 · 2022: $1,713 · 2023: $2,445 · 2024: $3,103 · 2025: $1,737.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,681 · Travel and Lodging: $603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,681.22 |
| Travel and Lodging | $603.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,939.16 | 2021-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $1,838.84 | 2021-2025 | Leqvio |
| Impulse Dynamics (USA) INC. | $1,165.35 | 2023-2024 | Optimizer, Optimizer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $807.06 | 2021-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $624.94 | 2022-2025 | Verquvo, Winrevair, Capvaxive |
| Astrazeneca Pharmaceuticals LP | $594.33 | 2021-2025 | Farxiga, Wainua |
| Bayer Healthcare Pharmaceuticals INC. | $459.83 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $445.80 | 2021-2024 | Xarelto |
| Novo Nordisk INC | $300.52 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $289.29 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $270.29 | 2021-2025 | Camzyos, Eliquis |
| Bridgebio Pharma, INC. | $243.29 | 2025 | Attruby |
| Alnylam Pharmaceuticals INC. | $141.91 | 2025 | Amvuttra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $101.32 | 2021-2025 | Lifevest |
| Cvrx, INC. | $101.00 | 2021-2025 | Barostim Neo System |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $91.33 | 2021-2022 | |
| Boston Scientific Corporation | $77.49 | 2024 | |
| Amarin Pharma, INC. | $76.77 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $73.15 | 2024 | Entyvio |
| Lexicon Pharmaceuticals, INC. | $49.38 | 2023-2024 | Inpefa |
| Vivaquant INC, Dba Rhythm Express | $46.50 | 2025 | Rhythm Express |
| Sanofi-Aventis U.S. LLC | $45.00 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $44.58 | 2021-2023 | Livalo |
| Abbott Laboratories | $31.82 | 2023-2025 | Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Arbor Pharmaceuticals, INC. | $27.60 | 2021 | |
| Inspire Medical Systems, INC. | $24.72 | 2023 | Inspire |
| Regeneron Healthcare Solutions, INC. | $23.77 | 2025 | Evkeeza |
| Silk Road Medical, INC. | $16.29 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Lilly USA, LLC | $16.29 | 2023 | Mounjaro |
| Scpharmaceuticals INC. | $16.01 | 2024 | |
| Bardy Diagnostics, INC. | $15.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marisa Austin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.